Horizon Diagnostics Triglycerides-Gpo Reagent

FDA 510(k) K933722 · Horizon Diagnostics, Inc.

Substantially Equivalent

510(k) numberK933722

Submission

Device name
Horizon Diagnostics Triglycerides-Gpo Reagent
Applicant
Horizon Diagnostics, Inc.
Ann Arbor, MI, US
Received
August 2, 1993
Decision date
June 13, 1996
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) statement available from FDA

Official FDA 510(k) record

Device classification

Product code
CDT – Lipase Hydrolysis/Glycerol Kinase Enzyme, Triglycerides
Device class
Class I (low risk)
Regulation
21 CFR 862.1705
Specialty
Clinical Chemistry

Other 510(k)s with product code CDT

510(k)DeviceApplicantDecision
K150819TriglyceridesCDT · Traditional Randox Laboratories Limited08/06/2015SE
K133067Advia Chemistry TRIGLYCERIDES_2 (TRIG_2) ReagentCDT · Traditional Siemens Healthcare Diagnostics, Inc.11/22/2013SE
K130332Vitros Chemistry Products Trig SlidesCDT · Special Ortho-Clinical Diagnostics, Inc.05/31/2013SE
K113830Vantera Clinical AnalyzerCDT · Traditional Liposcience08/30/2012SE
K102993Elitech Clinical Systems Triglycerides SL, Elitech Clinical Systems Cholesterol SLCDT · Traditional Seppim S.A.S.05/19/2011SE
K063804Olympus Triglyceride Test SystemCDT · Traditional Olympus America, Inc.03/23/2007SE
K043546Dimension RXL Max with Streamlab Analytical Workcell and Sample Transfer ModuleCDT · Special Dade Behring, Inc.01/18/2005SE
K034000Vitalab Triglycerides Reagent and Vitalab CalibratorCDT · Traditional Clinical Data, Inc.03/10/2004SE
K020488Careside TrglycerideCDT · Traditional Careside, Inc.04/15/2002SE
K010871TGL Flex Reagent CartridgeCDT · Traditional Dade Behring, Inc.07/09/2001SE

More from Dade Behring, Inc.

510(k)DeviceDecision
K971566Creatine Kinase-Mb Reagent SetCGS · Traditional 07/14/1997SE
K935712Iron/Tibc ReagentJIY · Traditional 09/20/1995SE
K930678AmylaseJFJ · Traditional 04/06/1994SE
K934533BUN-300/BUN-500 Urea Nitrogen ReagentCDQ · Traditional 11/26/1993SE
K930679Direct BilirubinCIG · Traditional 06/29/1993SE
K930074In-Vitro Diagnostic Reagent SetJGJ · Traditional 05/11/1993SE

Questions and answers

When was Horizon Diagnostics Triglycerides-Gpo Reagent cleared by the FDA?

Horizon Diagnostics Triglycerides-Gpo Reagent (K933722) received a 510(k) decision of Substantially Equivalent on June 13, 1996, 1,046 days after the submission was received.

What is the product code of K933722?

The FDA product code is CDT – Lipase Hydrolysis/Glycerol Kinase Enzyme, Triglycerides, a Class I (low risk) device regulated under 21 CFR 862.1705.